The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Proton pump inhibitor treatment for acute peptic ulcer bleeding
Leontiadis, G. I., McIntyre, L., Sharma, V. K., & Howden, C. W. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002094.pub2 · Cited by 232
RetractedHao (2015) · doi:10.1002/14651858 · Cited by 11,321
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
SIM, S., RISINGER, C., DAHL, M., AKLILLU, E., CHRISTENSEN, M., BERTILSSON, L., & INGELMANSUNDBERG, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.002 · Cited by 732
Li, X.-Q., Andersson, T. B., Ahlström, M., & Weidolf, L. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.821 · Cited by 644
Lanas, A., García-Rodríguez, L. A., Arroyo, M. T., Gomollón, F., Feu, F., González-Pérez, A., Zapata, E., Bástida, G., Rodrigo, L., Santolaria, S., et al. (2006) · Gut · doi:10.1136/gut.2005.080754 · Cited by 524
Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J., & Numans, M. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002095.pub5 · Cited by 507
Miner, P. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.09.053 · Cited by 442
Gastro-oesophageal reflux disease
Moayyedi, P., & Talley, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68932-0 · Cited by 426
Review article: the clinical pharmacology of proton pump inhibitors
SACHS, G., SHIN, J. M., & HOWDEN, C. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02943.x · Cited by 407
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Gulmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 341
Sreedharan, A., Martin, J., Leontiadis, G. I., Dorward, S., Howden, C. W., Forman, D., & Moayyedi, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005415.pub3 · Cited by 304
Lanas, A., García-Rodríguez, L. A., Arroyo, M. T., Bujanda, L., Gomollón, F., Forné, M., Aleman, S., Nicolas, D., Feu, F., González-Pérez, A., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01062.x · Cited by 298
Proton Pump Inhibitors: Pharmacology And Rationale For Use In Gastrointestinal Disorders
Richardson, P., Hawkey, C. J., & Stack, W. A. (1998) · Drugs · doi:10.2165/00003495-199856030-00002 · Cited by 297
Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy
JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., & KLEIBEUKER, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03127.x · Cited by 269
Vaira, D., Zullo, A., Vakil, N., Gatta, L., Ricci, C., Perna, F., Hassan, C., Bernabucci, V., Tampieri, A., & Morini, S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00006 · Cited by 266
Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication
(2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00002 · Cited by 262
Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies
Furuta, T., Shirai, N., Sugimoto, M., Nakamura, A., Hishida, A., & Ishizaki, T. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.153 · Cited by 257
Yuan, Y., Padol, I. T., & Hunt, R. H. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0393 · Cited by 250
García Rodríguez, L. A., & Barreales Tolosa, L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.007 · Cited by 249
Fuccio, L., Minardi, M. E., Zagari, R. M., Grilli, D., Magrini, N., & Bazzoli, F. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00008 · Cited by 248
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein
Pauli-Magnus, C., Rekersbrink, S., Klotz, U., & Fromm, M. F. (2001) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-001-0489-7 · Cited by 230
Self-citationPharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors
Blume, H., Donath, F., Warnke, A., & Schug, B. S. (2006) · Drug Safety · doi:10.2165/00002018-200629090-00002 · Cited by 216
Gralnek, I. M., Dulai, G. S., Fennerty, M. B., & Spiegel, B. M. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.013 · Cited by 198
Xie, H.-G., Stein, C. M., Kim, R. B., Wilkinson, G. R., Flockhart, D. A., & Wood, A. J. J. (1999) · Pharmacogenetics · doi:10.1097/00008571-199910000-00001 · Cited by 181
Clinical use and pharmacological properties of selective COX-2 inhibitors
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0400-7 · Cited by 179
Self-citationLow-dose aspirin and upper gastrointestinal damage:epidemiology, prevention and treatment
Lanas, A., & Scheiman, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x162656 · Cited by 177
Seven‐day therapy for Helicobacter pylori in the United States
Vakil, N. B., Lanza, F., Schwartz, H., & Barth, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02029.x · Cited by 175
Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 172
CYP2C19 Polymorphism and Proton Pump Inhibitors
Klotz, U., Schwab, M., & Treiber, G. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2004.pto950102.x · Cited by 166
Self-citationSystematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding
Leontiadis, G. I., Sharma, V. K., & Howden, C. W. (2005) · BMJ · doi:10.1136/bmj.38356.641134.8f · Cited by 164
Cheer, S. M., Prakash, A., Faulds, D., & Lamb, H. M. (2003) · Drugs · doi:10.2165/00003495-200363010-00006 · Cited by 161
Brown, T. J., Hooper, L., Elliott, R. A., Payne, K., Webb, R. T., Roberts, C., Rostom, A., & Symmons, D. P. M. (2006) · Health Technology Assessment · doi:10.3310/hta10380 · Cited by 161
Systematic review: proton pump inhibitor‐associated acute interstitial nephritis
SIERRA, F., SUAREZ, M., REY, M., & VELA, M. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03407.x · Cited by 160
Padol, S., Yuan, Y., Thabane, M., Padol, I. T., & Hunt, R. H. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00717.x · Cited by 160
hss, K. R., Lind, T., & Wilder‐Smith, C. H. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0804-6 · Cited by 153
Furuta, T., Shirai, N., Watanabe, F., Honda, S., Takeuchi, K., Iida, T., Sato, Y., Kajimura, M., Futami, H., Takayanagi, S., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127637 · Cited by 153
Baldwin, R. M., Ohlsson, S., Pedersen, R. S., Mwinyi, J., Ingelman‐Sundberg, M., Eliasson, E., & Bertilsson, L. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03104.x · Cited by 146
Leontiadis, G. I., Sharma, V. K., & Howden, C. W. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.3.286 · Cited by 145
Wang, L., Zhou, G., Zhu, B. Y., Wu, J., Wang, J., El‐Aty, A. M. A., Li, T., Liu, J., Tian-lun, Y., Wang, D., et al. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.014 · Cited by 145
Papatheodoridis, G., Sougioultzis, S., & Archimandritis, A. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.10.006 · Cited by 143
Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study
Robertson, D. J., Larsson, H., Friis, S., Pedersen, L., Baron, J. A., & Sørensen, H. T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.014 · Cited by 139
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors
Pantoflickova, D., Dorta, G. O., Ravic, M., Jornod, P., & Blum, A. L. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01496.x · Cited by 139
N??sdal, J., & Brown, K. A. (2006) · Drug Safety · doi:10.2165/00002018-200629020-00002 · Cited by 139
Pharmacogenomics of proton pump inhibitors
Furuta, T., Shirai, N., Sugimoto, M., Ohashi, K., & Ishizaki, T. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.2.181.27483 · Cited by 139
Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas
Jensen, R. T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_378.x · Cited by 138
Proton pump inhibitors and the kidney: critical review
Brewster, U. C., & Perazella, M. A. (2007) · Clinical Nephrology · doi:10.5414/cnp68065 · Cited by 137
Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding
Bardou, M., Toubouti, Y., Benhaberou‐Brun, D., Rahme, E., & Barkun, A. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02391.x · Cited by 132
Klotz, U. E. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44297 · Cited by 132
Self-citationChronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., Propert, K., Hwang, W., Sedarat, A., & Lewis, J. D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.022 · Cited by 125
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study
Diav‐Citrin, O., Arnon, J., Shechtman, S., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02306.x · Cited by 116
Proton pump inhibitors and gastric neoplasia: Figure 1
Kuipers, E. J. (2006) · Gut · doi:10.1136/gut.2005.090514 · Cited by 115
Leontiadis, G. I., Sharma, V. K., & Howden, C. W. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61024-0 · Cited by 114
Pace, F., Tonini, M., Pallotta, S., Molteni, P., & Porro, G. B. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03381.x · Cited by 112
Proton pump inhibitor‐induced acute interstitial nephritis
Härmark, L., van der Wiel, H. E., de Groot, M., & van Grootheest, A. C. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02927.x · Cited by 108
Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori
Klotz, U. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038030-00004 · Cited by 105
Self-citationPadol, S., Yuan, Y., Thabane, M. E., Padol, I. T., & Hunt, R. H. (2007) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45188 · Cited by 105
Leontiadis, G. I., Sharma, V. K., & Howden, C. W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02441.x · Cited by 98
Schwab, M. G., Schaeffeler, E., Klotz, U. E., & Treiber, G. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.05.002 · Cited by 97
Self-citationFuruta, T., Sugimoto, M., Shirai, N., & Ishizaki, T. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.9.1199 · Cited by 95
Summing the risk of NSAID therapy
Scheiman, J. M., & Fendrick, A. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60722-3 · Cited by 94
Hunfeld, N., Mathôt, R. A. A., Touw, D. J., van Schaik, R. H., Mulder, P. G. H., Franck, P., Kuipers, E. J., & Geus, W. P. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03094.x · Cited by 93
Andriulli, A., Annese, V., Caruso, N., Pilotto, A., Accadia, L., Niro, G. A., Quitadamo, M., Merla, A., Fiorella, S., & Leandro, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40636.x · Cited by 92
Hassan‐Alin, M., Andersson, T., Niazi, M., & R�hss, K. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0841-1 · Cited by 92
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes
Yasui‐Furukori, N., Takahata, T., Nakagami, T., Yoshiya, G., Inoue, Y., Kaneko, S., & Tateishi, T. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02047.x · Cited by 90
Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease
Fass, R. (2007) · Drugs · doi:10.2165/00003495-200767110-00001 · Cited by 89
Khuroo, M. S., Khuroo, M. S., FARAHAT, K. L., & Kagevi, I. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03441.x · Cited by 89
Tomilo, D. L., Smith, P. F., Ogundele, A., DiFrancesco, R., Berenson, C. S., Eberhardt, E., Bednarczyk, E. M., & Morse, G. D. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.341 · Cited by 89
How Can the Current Strategies for Helicobacter pylori Eradication Therapy be Improved?
Ford, A. C., & Moayyedi, P. (2003) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2003/714124 · Cited by 87
Miwa, H., Sasaki, M., Furuta, T., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03350.x · Cited by 85
Bleeding Peptic Ulcer in the Elderly: Risk Factors and Prevention Strategies
Zullo, A., Hassan, C., Campo, S. M. A., & Morini, S. (2007) · Drugs & Aging · doi:10.2165/00002512-200724100-00003 · Cited by 85
Horn, J. R., & Howden, C. W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02714.x · Cited by 79
Gisbert, J. P., & Pajares, J. M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02418.x · Cited by 78
On-Demand Therapy for Gastroesophageal Reflux Disease
Metz, D. C., Inadomi, J. M., Howden, C. W., van Zanten, S. J. V., & Bytzer, P. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00998.x · Cited by 78
Comparing Rates of Dyspepsia with Coxibs vs NSAID+PPI: A Meta-Analysis
Spiegel, B. M. R., Farid, M., Dulai, G. S., Gralnek, I. M., & Kanwal, F. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.020 · Cited by 74
石澤, 幸., Yasui‐Furukori, N., Takahata, T., Sasaki, M., & Tateishi, T. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544110-00005 · Cited by 71
Zapata-Colindres, J. C., Zepeda-Gómez, S., Montaño‐Loza, A. J., Vázquez-Ballesteros, E., Villalobos, J. J., & Valdovinos‐Andraca, F. (2006) · Canadian Journal of Gastroenterology · doi:10.1155/2006/175217 · Cited by 65
Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety
Tolia, V. K., & Boyer, K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9880-7 · Cited by 65
Sequential regimens for Helicobacter pylori eradication
Moayyedi, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61455-x · Cited by 63
Leest, H. T. J. I. D., Steen, K. S. S., Lems, W. F., Bijlsma, J. W. J., van de Laar, M. A. F. J., HUISMAN, A. M., Vonkeman, H. E., Houben, H., Kadir, S. W., Kostense, P. J., et al. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00543.x · Cited by 60
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole
Sostek, M. B., Chen, Y., & Andersson, T. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02889.x · Cited by 60
Schmitt, C. M., Lightdale, C. J., Hwang, C., & Hamelin, B. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9062-4 · Cited by 58
Schwab, M. G., Klotz, U. E., Hofmann, U., Schaeffeler, E., LEODOLTER, A., Malfertheiner, P., & Treiber, G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.017 · Cited by 57
Self-citationCaos, A., Breiter, J. R., Perdomo, C. A., & Barth, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02555.x · Cited by 55
Treatment of Gastroesophageal Reflux Disease*
Pettit, M. (2005) · Pharmacy World & Science · doi:10.1007/s11096-005-4798-7 · Cited by 55
Functional Heartburn and Non-Erosive Reflux Disease
Savarino, V., Savarino, E. V., Parodi, A. F., et al. (2007) · Digestive Diseases · doi:10.1159/000103879 · Cited by 54
Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses
Gremse, D. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.10.1663 · Cited by 54
Effects of clarithromycin on lansoprazole pharmacokinetics betweenCYP2C19genotypes
Saito, M., Yasui‐Furukori, N., Uno, T., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02329.x · Cited by 47
Shimatani, T., INOUE, M., Kuroiwa, T., XU, J., Mieno, H., Nakamura, M., & Tazuma, S. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.012 · Cited by 46
Spiegel, B. M. R., Dulai, G. S., Lim, B. S., Mann, N. S., Kanwal, F., & Gralnek, I. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.019 · Cited by 45
Calabresi, L., Pazzucconi, F., Ferrara, S., Paolo, A. D., Tacca, M. D., & Sirtori, C. R. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.10.010 · Cited by 41
Pace, F., Annese, V., Prada, A., Zambelli, A., Casalini, S., Nardini, P., & Porro, G. B. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.04.026 · Cited by 35
Akhtar, A. J., & Shaheen, M. A. (2007) · PubMed · Cited by 35
Miehlke, S., Madisch, A., Kirsch, C., Lindner, F., Kuhlisch, E., Laass, M. W., Knoth, H., Morgner, A., & Labenz, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02432.x · Cited by 35
Armstrong, D., James, C., Camacho, F., Chen, Y., Horbay, G. L. A., TEIXEIRA, B., & Husein-Bhabha, F. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03160.x · Cited by 35
Johnson, D. A., STACY, T., Ryan, M. J., Wootton, T., Willis, J., Hornbuckle, K., Brooks, W. D., & DOVIAK, M. J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02534.x · Cited by 34
Seguridad de la utilización de los inhibidores de la bomba de protones
Esplugues, J. V., Martí‐Cabrera, M., & Ponce, J. (2006) · Medicina Clínica · doi:10.1157/13095825 · Cited by 33
Egan, L. J., Myhre, G. M., Mays, D. C., Dierkhising, R., Kammer, P. P., & Murray, J. A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01645.x · Cited by 33
Portolés, A., Calvo, A., Terleira, A. I., et al. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291624 · Cited by 33
Shimatani, T., Inoue, M., Kuroiwa, T., Horikawa, Y., Mieno, H., & Nakamura, M. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01804.x · Cited by 32
Miura, M., Inoue, K., Kagaya, H., Satoh, S., Tada, H., SAGAE, Y., Habuchi, T., & Suzuki, T. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.544 · Cited by 30
Fisher, L., Fisher, A., Pavli, P., & DAVIS, M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03187.x · Cited by 30
Update on therapeutic options for Helicobacter pylori-related diseases
Mégraud, F. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0071-4 · Cited by 28
Norris, V., Baisley, K. J., DUNN, K., Warrington, S., & Morocutti, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03221.x · Cited by 27
Singh, M., Dhindsa, G., Friedland, S., & Triadafilopoulos, G. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03450.x · Cited by 26
Pilotto, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i33.4467 · Cited by 25
Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline
Pan, P., Goldwater, Zhang, Pilmer, & Hunt (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00703.x · Cited by 21
Medical management of gastroesophageal reflux disease
Ferguson, D. D., & DeVault, K. R. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.39 · Cited by 21
Giannini, E. G., Bilardi, C., Dulbecco, P., Mamone, M., Santi, M. L., Testa, R., Mansi, C., & Savarino, V. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200607000-00010 · Cited by 20
Lin, C., Yang, J., Uang, Y., Chern, H., & Wang, T. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.711.32177 · Cited by 18
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes
Shimizu, M., Uno, T., Yasui‐Furukori, N., et al. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0152-9 · Cited by 17
Katz, P. O. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02801.x · Cited by 15
Acid-related disorders and use of antisecretory medication.
Lassen, A. T. (2007) · PubMed · Cited by 15
Hartmann, D., Eickhoff, A., Damian, U., Riemann, J. F., & Schilling, D. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000252628.57925.32 · Cited by 14
Takahata, T., Yasui‐Furukori, N., Yoshiya, G., Uno, T., Sugawara, K., & Tateishi, T. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto940509.x · Cited by 10
Louw, J. A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000245532.12648.aa · Cited by 9
Celecoxib versus a Non-Selective NSAID Plus Proton-Pump Inhibitor
Chen, J. T., Pucino, F., & Resman‐Targoff, B. H. (2006) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v20n04_05 · Cited by 7
Cited by
Barkun, A. N., Bardou, M., Kuipers, E. J., Sung, J., Hunt, R. H., Martel, M., Sinclair, P., & for the International Consensus Upper Gastrointestinal Bleeding Conference Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00009 · Cited by 1,163
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
Writing Committee Members, Abraham, N. S., Hlatky, M. A., Antman, E. M., Bhatt, D. L., Bjorkman, D. J., Clark, C. B., Furberg, C. D., Johnson, D. A., Kahi, C. J., et al. (2010) · Circulation · doi:10.1161/cir.0b013e318202f701 · Cited by 451
Metadata
- Authors
- Shi, S., & Klotz, U.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2008-08-05
- Volume
- 64
- Issue
- 10
- Pages
- 935-951
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2023160406
- Cited by
- 314
- References
- 123
- FWCI
- 23.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.